448 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:58
499 0 Li Wanxi 2016-8-22 publish Last reply on 2016-8-22 09:28
471 0 Fei Yifei 2016-8-22 publish Last reply on 2016-8-22 09:23
522 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 12:03
500 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:41
502 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 11:14
514 0 Li Wanxi 2016-8-21 publish Last reply on 2016-8-21 10:42
614 0 Fei Yifei 2016-8-20 publish Last reply on 2016-8-20 21:47
463 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 20:23
572 0 Xinjiang Wanyintong 2016-8-20 publish Last reply on 2016-8-20 19:57
644 0 Wuhan Medical 2016-8-20 publish Last reply on 2016-8-20 15:40
434 0 special characteristics 2016-8-20 publish Last reply on 2016-8-20 09:32
412 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 16:36
530 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 14:56
592 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 11:52
461 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 10:29
501 0 Fei Yifei 2016-8-19 publish Last reply on 2016-8-19 09:23
535 0 special characteristics 2016-8-19 publish Last reply on 2016-8-19 09:03
593 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 19:22
461 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 17:20
556 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 16:14
603 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 13:00
475 0 Fei Yifei 2016-8-18 publish Last reply on 2016-8-18 11:19
506 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 11:17
509 0 Li Wanxi 2016-8-18 publish Last reply on 2016-8-18 10:49
Point rules of this version Post Rebroadcast to the audience